IL-18-armored CAR T Drives Remissions in Relapsed B-Cell LeukemiaByDr. Matthew P. ConnorDecember 19th 2025An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with manageable side effects.